C
ClinBrain
Develops a hospital information integration platform by digitizing and standardizing patient data with medical and clinical data
About ClinBrain
Established in 2013, Shanghai ClinBrain Information Technology Co., Ltd. operates as a specialized medical big data service provider in China. The company focuses on developing hospital information integration platforms, medical big data centers, and intelligent data application services. Its target clients are primarily large hospitals and healthcare management departments across numerous provinces in China. The business model centers on providing these institutions with products and services for data integration, governance, and utilization, helping them enhance operational efficiency and clinical research capabilities.
ClinBrain was founded by Liao Jieyuan, and its management and core technical teams possess extensive experience in healthcare systems and big data development. The company has achieved significant milestones, including securing its Series A financing of 68 million RMB in 2018, followed by a Series B round of over 100 million RMB in 2020. By 2022, ClinBrain completed a substantial Series C funding round of nearly 200 million RMB, led by Legend Capital, to further invest in the fusion of big data and AI for the medical sector.
The company's product suite is built around creating comprehensive data centers for healthcare institutions. Key offerings include a Clinical Data Center (CDR) to unify data for better service quality, an Operational Data Center (ODR) for management decision support, and a Research Data Center (RDR) to support scientific studies. ClinBrain also provides a Health Medical Data Lake solution and an API sharing mid-platform to reduce development costs and improve data service reusability. The firm has actively participated in setting industry standards, contributing to various guidelines for hospital information integration and clinical data systems in China.
Source: Dealroom company dataKnowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES C✓Equity / VC | Oct 2022 | $27M | $110M | Legend Capital | ↗ |
| SERIES BEquity / VC | Oct 2020 | $14M | $55M | Qianhai FOF · Med-Fine Capital · GeniLink Capital | ↗ |
Growth signals
Latest recorded traffic for ClinBrain is 910 monthly website visits, down 35% over the last three months. ClinBrain's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
Qianhai FOF
Med-Fine Capital
GeniLink Capital
Series B and later1 investor entered at this stage
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about ClinBrain on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See ClinBrain’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.








